InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（6 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Olivo Alicia C, VP Exécutif. Director active across 1 company, notably Neogenomics INC. Aggregated, 25 disclosures have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €229k. History available since 1 May 2023. The latest transaction was disclosed on 1 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Olivo Alicia C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报25 总计
2,692 股0Common StockSEC:0001628280-26-060499:0
3,944 股0Common StockSEC:0001628280-26-034620:0
21,079 股0Common StockSEC:0001628280-26-011097:0
59,382 股0Common StockSEC:0001628280-26-002198:0
8,977 股@ US$10.0525.5% 占其流量Common StockSEC:0001628280-25-054270:0
4,918 股@ US$10.0018.3% 占其流量Common StockSEC:0001628280-25-045529:0
1,666 股0Common StockSEC:0001077183-25-000165:0
14 股0Common StockSEC:0001951869-25-000002:0
6,503 股0Common StockSEC:0001077183-25-000106:0
652 股0Common StockSEC:0001077183-25-000081:0
8,443 股0Common StockSEC:0001077183-25-000043:0
6,502 股0Common StockSEC:0001077183-24-000170:0
5,175 股@ US$15.357540.3% 占其流量Common StockSEC:0001077183-24-000162:0
1,666 股0Common StockSEC:0001077183-24-000146:0
1,040 股@ US$16.05338.1% 占其流量Common StockSEC:0001077183-24-000141:0
14 股0Common StockSEC:0001077183-24-000112:0
1,049 股@ US$15.748.1% 占其流量Common StockSEC:0001077183-24-000079:0
6,502 股0Common StockSEC:0001077183-24-000074:0
652 股0Common StockSEC:0001077183-24-000061:0
2,587 股@ US$14.964419.3% 占其流量Common StockSEC:0001077183-24-000013:0
2,669 股@ US$18.3924.2% 占其流量Common StockSEC:0001077183-23-000140:0
14 股0Common StockSEC:0001077183-23-000127:0
1,666 股0Common StockSEC:0001077183-23-000125:0
14 股0Common StockSEC:0001077183-23-000092:0
662 股0Common StockSEC:0001077183-23-000032:0
25 条申报中的 25 条
About Olivo Alicia C
Olivo Alicia C is VP Exécutif and, at Neogenomics INC (XNAS), serves as EVP, GC & Business Development. Across 24 filings in total, the 24 sampled filings cover the period from 2023-05-03 to 2026-05-13, with EUR 0 in buys and EUR 229181 in sells, and the most common transaction nature is Tax withholding.
